trials breast Triple negative cancer
You may be able to continue to have pembrolizumab after 2 years if your cancer got worse progressed at the end of treatment. Phase 2 About Research at The Christie. Most triple negative tumors are basal-like and most basal-like tumors are triple negative. Your opinions are important to us.
This document is subject to copyright. Part 2 This part of the trial is also randomised. IMP with orphan designation in the indication. Follow up